Literature DB >> 32501664

Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?

Milton C Weinstein1, Kenneth A Freedberg1, Emily P Hyle1, A David Paltiel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32501664     DOI： 10.1056/NEJMp2017739

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

Review 1.  Antibody tests for COVID-19.

Authors:  Jonathan Kopel; Hemant Goyal; Abhilash Perisetti
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-13

Review 2. 

Authors:  Paul Van Caeseele; Dana Bailey; Sarah E Forgie; Tanis C Dingle; Mel Krajden
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

3.  Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2.

Authors:  Raymond T Suhandynata; Melissa A Hoffman; Deli Huang; Jenny T Tran; Michael J Kelner; Sharon L Reed; Ronald W McLawhon; James E Voss; David Nemazee; Robert L Fitzgerald
Journal:  Clin Chem       Date:  2021-01-30       Impact factor: 8.327

Review 4.  Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.

Authors:  Seyed Hamid Safiabadi Tali; Jason J LeBlanc; Zubi Sadiq; Oyejide Damilola Oyewunmi; Carolina Camargo; Bahareh Nikpour; Narges Armanfard; Selena M Sagan; Sana Jahanshahi-Anbuhi
Journal:  Clin Microbiol Rev       Date:  2021-05-12       Impact factor: 26.132

5.  Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays.

Authors:  Christos Fotis; Nikolaos Meimetis; Nikos Tsolakos; Marianna Politou; Karolina Akinosoglou; Vaia Pliaka; Angeliki Minia; Evangelos Terpos; Ioannis P Trougakos; Andreas Mentis; Markos Marangos; George Panayiotakopoulos; Meletios A Dimopoulos; Charalampos Gogos; Alexandros Spyridonidis; Leonidas G Alexopoulos
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

6.  Will all SARS-CoV-2 seroprevalence surveys provide the right picture?

Authors:  F Valent; F Gongolo
Journal:  Public Health       Date:  2020-07-21       Impact factor: 2.427

7.  Coronavirus antibody positive tests and continued use of personal protective equipment throughout the pandemic.

Authors:  J B T Herron; J Dennis; P A Brennan
Journal:  Br J Oral Maxillofac Surg       Date:  2020-06-20       Impact factor: 1.651

8.  Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals.

Authors:  Georg M N Behrens; Anne Cossmann; Metodi V Stankov; Bianca Schulte; Hendrik Streeck; Reinhold Förster; Berislav Bosnjak; Stefanie Willenzon; Anna-Lena Boeck; Anh Thu Tran; Thea Thiele; Theresa Graalmann; Moritz Z Kayser; Anna Zychlinsky Scharff; Christian Dopfer; Alexander Horke; Isabell Pink; Torsten Witte; Martin Wetzke; Diana Ernst; Alexandra Jablonka; Christine Happle
Journal:  Infect Dis Ther       Date:  2020-09-04

9.  Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample.

Authors:  P Maver Vodičar; A Oštrbenk Valenčak; B Zupan; T Avšič Županc; S Kurdija; M Korva; M Petrovec; J Demšar; N Knap; E Štrumbelj; V Vehovar; M Poljak
Journal:  Clin Microbiol Infect       Date:  2020-07-18       Impact factor: 13.310

10.  Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using a High-Throughput, Fully Automated Liquid-Handling Robotic System.

Authors:  Donna Grace Karp; Deanne Cuda; Devangkumar Tandel; Kenneth Danh; Peter V Robinson; David Seftel; Honglin Tian; Mark Pandori; Kevin W P Miller; Cheng-T Tsai
Journal:  SLAS Technol       Date:  2020-08-20       Impact factor: 3.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.